A

Active Director Additional Director DIN 10141115
DIN 10141115 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Anurag

Data last updated:

Anurag is an Additional Director at Epcure Pharmalab Private Limited (since 2023). The company operates in Pharma. Epcure Pharmalab Private Limited reported revenue of ₹2.91 Cr (FY 2022).

DIN 10141115
Primary Designation Additional Director
Industry Pharma
First Appointment 27 Apr 2023
Oldest Company Age 7 yrs
Largest company Epcure Pharmalab Private Limited · ₹2.91 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epcure Pharmalab Private Limited U51909MP2019PTC048441
Additional Director27 Apr 20232019₹2.91 Cr (FY 2022)Active

Board colleagues of Anurag

NameDINCompanyDesignation
Himanshu Choudhary08433472Epcure Pharmalab Private LimitedDirector

Directorship timeline

Open interactive timeline →
Epcure Pharmalab Private Limited
Premium access

Shareholding and investment profile for Anurag

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag

Anurag currently holds 1 directorship: Epcure Pharmalab Private Limited (Additional Director, since 27 Apr 2023, revenue ₹2.91 Cr (FY 2022)).

Anurag was first appointed on 27 Apr 2023 as Additional Director at Epcure Pharmalab Private Limited.

The current boards of Anurag's companies include Himanshu Choudhary (Epcure Pharmalab Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available